FDAFDA · Food and drugs·Recall number D-0772-2021
Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.
Published September 1, 2021 · Recall initiated: July 2, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Temperature abuse: the firm received customer complaints of unusual grittiness in the product.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ATOVAQUONE ORAL SUSPENSION
- Manufacturer
- KVK-Tech, Inc.
- Distributor
- Product was distributed to one distributor who may have further distributed Nationwide in the USA.
- UPC
- 0310702223219
- Lot
- Batch # 16653A, 16654A, Exp 12/2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.